Final analysis of the phase I/II study of CC-486 (oral azacitidine) maintenance therapy after allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) Meeting Abstract
| Authors: | de Lima, M.; Oran, B.; Champlin, R. E.; Papadopoulos, E. B.; Giralt, S. A.; Scott, B. L.; William, B. M.; Hetzer, J.; Hubbell, B.; Skikne, B. S.; Craddock, C. |
| Abstract Title: | Final analysis of the phase I/II study of CC-486 (oral azacitidine) maintenance therapy after allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419704104 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.4512.4512 |
| Notes: | Meeting Abstract: 4512 -- Source: Wos |
